Dalfampridine
FDA Approved: * October 24, 2018Pharm Company: * ROXANE
Category: Multiple Sclerosis
4-Aminopyridine (4-AP, fampridine, dalfampridine) is an organic compound with the chemical formula C5H4N–NH2. The molecule is one of the three isomeric amines of pyridine. It is used as a research tool in characterizing subtypes of the potassium channel. It has also been used as a drug, to manage some of the symptoms of multiple sclerosis,[6][7] and is indicated for symptomatic improvement of walking in adults with several variations of the disease.&am... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release
NDC: 0054-0479
Labeler:
West-ward Pharmaceuticals Corp.
Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release
NDC: 0378-0509
Labeler:
Mylan Pharmaceuticals Inc.
Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release
NDC: 0378-4504
Labeler:
Mylan Pharmaceuticals Inc.
Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release
NDC: 0591-2533
Labeler:
Actavis Pharma, Inc.
Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release
NDC: 16729-292
Labeler:
Accord Healthcare Inc.
Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release
NDC: 51407-246
Labeler:
Golden State Medical Supply, Inc.
Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release
NDC: 51407-876
Labeler:
Golden State Medical Supply, Inc.
Dalfampridine 10 mg Oral Tablet, Extended Release
NDC: 62756-429
Labeler:
Sun Pharmaceutical Industries, Inc.
Dalfampridine 10 mg Oral Tablet, Film Coated, Extended Release
NDC: 63629-9450
Labeler:
Bryant Ranch Prepack